- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/56 - BenzopyrazolesHydrogenated benzopyrazoles
Patent holdings for IPC class C07D 231/56
Total number of patents in this class: 1734
10-year publication summary
|
114
|
107
|
120
|
119
|
103
|
105
|
87
|
101
|
100
|
85
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3737 |
34 |
| Nerviano Medical Sciences S.r.l. | 253 |
28 |
| Takeda Pharmaceutical Company Limited | 2717 |
27 |
| Glaxo Group Limited | 4117 |
23 |
| Bristol-myers Squibb Company | 4820 |
23 |
| Array BioPharma Inc. | 475 |
22 |
| F. Hoffmann-La Roche AG | 7933 |
21 |
| LG Chem, Ltd. | 17679 |
21 |
| Merck Sharp & Dohme Corp. | 2190 |
21 |
| Janssen Pharmaceutica N.V. | 3351 |
21 |
| Abbvie Inc. | 1815 |
20 |
| Bayer Pharma AG | 1048 |
17 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 842 |
17 |
| Boehringer Ingelheim International GmbH | 4635 |
15 |
| The Regents of the University of California | 20289 |
14 |
| AstraZeneca AB | 2858 |
14 |
| Pfizer Inc. | 3401 |
14 |
| Merck Patent GmbH | 5759 |
13 |
| Abbott Laboratories | 2360 |
13 |
| Genentech, Inc. | 4015 |
12 |
| Other owners | 1344 |